Skip to content

Clinical trials

Phase 3 Diabetes Mellitus, Type 2 trials in Switzerland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus, Type 2 Phase: Phase 3 Country / region: Switzerland Clear all

49 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20021
20032
20046
20057
20066
20073
20082
20091
20105
20112
20131
20152
20162
20171
20181
20201
20221
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed40
Terminated7
Active, not recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S12
Novartis Pharmaceuticals10
Boehringer Ingelheim5
AstraZeneca4
Sanofi3
Bayer2
Hoffmann-La Roche2
Lexicon Pharmaceuticals2
Novartis2
Bristol-Myers Squibb1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 249
Diabetes Mellitus14
Obesity3
Cardiovascular Diseases2
Diabetic Nephropathies2
Heart Failure2
Kidney Diseases2
Overweight2
Renal Insufficiency, Chronic2
COVID-191

Trials

Showing 1 to 25 of 49. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.